aminacrine has been researched along with Acute Confusional Senile Dementia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Carletti, E; Jean, L; Nachon, F; Nicolet, Y; Renard, PY; Ronco, C; Trovaslet, M | 1 |
| Ahmad, A; Akhtar, S; Akram, A; Arif, M; Munawar, R; Mushtaq, N; Saeed, SMG; Saify, ZS; Usmani, S | 1 |
| Bai, Y; Chen, W; He, J; He, M; Hou, D; Jiang, Q; Li, X; Liu, X; Luo, B; Ma, Q; Ma, X; Qin, Y; Shang, L; Sun, L; Tang, M; Wang, T; Wang, X; Wu, L; Xiao, S; Xie, H; Zhao, Z | 1 |
| Chierici, S; Demeunynck, M; Dubois-Dauphin, M; Garin, D; Ghezzi, C; Gözel, B; Laferla, FM; Marti-Battle, D; Meyronet, D; Millet, P; Oukhatar, F; Perret, P; Sallanon Moulin, M; Streichenberger, N; Touret, M; Virgone-Carlotta, A | 1 |
| Ahmed, A; Akhtar, S; Ansari, S; Arif, M; Arif, S; Meer, S; Munawar, R; Mushtaq, N; Saify, ZS | 1 |
| Irie, T; Kato, T; Nakamura, Y; Natori, K; Utsumi, H; Xu, M; Yamamoto, T | 1 |
1 trial(s) available for aminacrine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial.
Topics: Acetylcholinesterase; Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Aminacrine; China; Cholinesterase Inhibitors; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; GPI-Linked Proteins; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Severity of Illness Index; Time Factors; Treatment Outcome | 2017 |
5 other study(ies) available for aminacrine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase.
Topics: Acetylcholinesterase; Alzheimer Disease; Aminoquinolines; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Crystallography, X-Ray; Humans; Tacrine | 2013 |
Molecular docking, synthesis and biological evaluation of phenacyl derivatives of 9-aminoacridine as anti-Alzheimer's agent.
Topics: Acetylcholinesterase; Alzheimer Disease; Aminacrine; Antioxidants; Cholinesterase Inhibitors; Crystallography, X-Ray; Drug Evaluation, Preclinical; Humans; Molecular Docking Simulation; Structure-Activity Relationship | 2020 |
COB231 targets amyloid plaques in post-mortem human brain tissue and in an Alzheimer mouse model.
Topics: Alzheimer Disease; Aminacrine; Animals; Autopsy; Brain; Disease Models, Animal; Female; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Plaque, Amyloid; Proflavine; Sensitivity and Specificity; Staining and Labeling | 2015 |
Synthesis of 9-Aminoacridine Derivatives as Anti-Alzheimer Agents.
Topics: Alzheimer Disease; Aminacrine; Cholinesterase Inhibitors; Humans; In Vitro Techniques | 2016 |
Determination of basal acetylcholine release in vivo by rat brain dialysis with a U-shaped cannula: effect of SM-10888, a putative therapeutic drug for Alzheimer's disease.
Topics: Acetylcholine; Alzheimer Disease; Aminacrine; Animals; Brain; Catheterization; Cholinesterase Inhibitors; Dialysis; Equipment Design; Male; Rats; Rats, Inbred Strains | 1991 |